Latin America, Middle East & Africa Stroke Management Market (2018 - 2024)
The Latin America, Middle East and Africa Stroke Management Market would witness market growth of 8.0% CAGR during the forecast period (2018 – 2024). Stroke is a medical emergency which occurs when the flow of the blood is restricted to the brain and as a result, brain cells start dying. Rise in incidence and prevalence of chronic diseases has been a major factor that is responsible for the growth of the stroke management market. Additionally, growing geriatric population, which is highly susceptible to strokes, growing diabetic population and usage of tobacco are other factors that are driving the growth of the market. However, the cost associated with the treatment and stringent government regulations pertaining to the approval of new and advances devices and drugs would limit the market growth. Rising investments to upgrade healthcare systems and demand for technologically advanced devices for rapid & accurate distribution of medicines are the factors that are driving the market in the region. Research and development activities in the region would further add to the market attractiveness in the region.
Based on Application, the market is segmented into Ischemic Stroke and Hemorrhagic Stroke. Based on Type, the market is segmented into Diagnostics and Therapeutics. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include ABBOTT Laboratories, B. Braun Melsungen Ag, Boston Scientific Corporation, Cardinal Health, Inc., Ge Healthcare, Glaxosmithkline Plc, Medtronic Plc., Siemens Aktiengesellschaft, Merck & Co., Inc., and Bristol-Myers Squibb Company.
Based on Application, the market is segmented into Ischemic Stroke and Hemorrhagic Stroke. Based on Type, the market is segmented into Diagnostics and Therapeutics. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include ABBOTT Laboratories, B. Braun Melsungen Ag, Boston Scientific Corporation, Cardinal Health, Inc., Ge Healthcare, Glaxosmithkline Plc, Medtronic Plc., Siemens Aktiengesellschaft, Merck & Co., Inc., and Bristol-Myers Squibb Company.
CHAPTER 1. MARKET SCOPE & METHODOLOGY
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Stroke Management Market, by Type
1.4.2 LAMEA Stroke Management Market, by Application
1.4.3 LAMEA Stroke Management Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Players Outlook for the Market
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. LAMEA STROKE MANAGEMENT MARKET BY TYPE
3.1.1 LAMEA Diagnostics Stroke Management Market by Country
3.1.1.1 LAMEA Stroke Management Market by Diagnostics Type
3.1.1.1.1 LAMEA Stroke Management Computed Tomography Scan (CT Scan) Market by Country
3.1.1.1.2 LAMEA Stroke Management Magnetic Resonance Imaging (MRI) Market by Country
3.1.1.1.3 LAMEA Stroke Management Echocardiography Market by Country
3.1.1.1.4 LAMEA Stroke Management Carotid Ultrasound Market by Country
3.1.1.1.5 LAMEA Stroke Management Cerebral Angiography Market by Country
3.1.1.1.6 LAMEA Stroke Management Electrocardiography Market by Country
3.1.1.1.7 LAMEA Other Diagnostics Type Stroke Management Market by Country
3.1.2 LAMEA Therapeutics Stroke Management Market by Country
3.1.2.1 LAMEA Stroke Management Market by Therapeutics Type
3.1.2.1.1 LAMEA Tissue Plasminogen Activator Stroke Management Market by Country
3.1.2.1.2 LAMEA Anticoagulant Stroke Management Market by Country
3.1.2.1.3 LAMEA Antiplatelet Stroke Management Market by Country
3.1.2.1.4 LAMEA Other Therapeutics Type Stroke Management Market by Country
CHAPTER 4. LAMEA STROKE MANAGEMENT MARKET BY APPLICATION
4.1.1 LAMEA Ischemic Stroke Management Market by Country
4.1.2 LAMEA Hemorrhagic Stroke Management Market by Country
CHAPTER 5. LAMEA STROKE MANAGEMENT MARKET BY COUNTRY
5.1 Brazil Stroke Management Market
5.1.1 Brazil Stroke Management Market by Type
5.1.1.1 Brazil Stroke Management Market by Diagnostics Type
5.1.1.2 Brazil Stroke Management Market by Therapeutics Type
5.1.2 Brazil Stroke Management Market by Application
5.2 Argentina Stroke Management Market
5.2.1 Argentina Stroke Management Market by Type
5.2.1.1 Argentina Stroke Management Market by Diagnostics Type
5.2.1.2 Argentina Stroke Management Market by Therapeutics Type
5.2.2 Argentina Stroke Management Market by Application
5.3 UAE Stroke Management Market
5.3.1 UAE Stroke Management Market by Type
5.3.1.1 UAE Stroke Management Market by Diagnostics Type
5.3.1.2 UAE Stroke Management Market by Therapeutics Type
5.3.2 UAE Stroke Management Market by Application
5.4 Saudi Arabia Stroke Management Market
5.4.1 Saudi Arabia Stroke Management Market by Type
5.4.1.1 Saudi Arabia Stroke Management Market by Diagnostics Type
5.4.1.2 Saudi Arabia Stroke Management Market by Therapeutics Type
5.4.2 Saudi Arabia Stroke Management Market by Application
5.5 South Africa Stroke Management Market
5.5.1 South Africa Stroke Management Market by Type
5.5.1.1 South Africa Stroke Management Market by Diagnostics Type
5.5.1.2 South Africa Stroke Management Market by Therapeutics Type
5.5.2 South Africa Stroke Management Market by Application
5.6 Nigeria Stroke Management Market
5.6.1 Nigeria Stroke Management Market by Type
5.6.1.1 Nigeria Stroke Management Market by Diagnostics Type
5.6.1.2 Nigeria Stroke Management Market by Therapeutics Type
5.6.2 Nigeria Stroke Management Market by Application
5.7 Rest of LAMEA Stroke Management Market
5.7.1 Rest of LAMEA Stroke Management Market by Type
5.7.1.1 Rest of LAMEA Stroke Management Market by Diagnostics Type
5.7.1.2 Rest of LAMEA Stroke Management Market by Therapeutics Type
5.7.2 Rest of LAMEA Stroke Management Market by Application
CHAPTER 6. COMPANY PROFILES
6.1 B. Braun Melsungen AG.
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental Analysis
6.1.4 Research & Development Expense
6.2 ABBOTT
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Regional & Segmental Analysis
6.2.4 Research & Development Expense
6.3 Cardinal Health
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental Analysis
6.4 Medtronic Plc.
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expense
6.5 General Electric (GE) (GE Healthcare)
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.5.4 Research & Development Expense
6.6 Siemens Healthineers
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental Analysis
6.6.4 Research & Development Expense
6.7 Bristol-Myers Squibb
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Regional Analysis
6.7.4 Research & Development Expense
6.8 Merck & Company Inc.
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental Analysis
6.8.4 Research & Development Expense
6.9 Glaxosmithkline Plc.
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Segmental Analysis
6.9.4 Research & Development Expense
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Stroke Management Market, by Type
1.4.2 LAMEA Stroke Management Market, by Application
1.4.3 LAMEA Stroke Management Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Players Outlook for the Market
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. LAMEA STROKE MANAGEMENT MARKET BY TYPE
3.1.1 LAMEA Diagnostics Stroke Management Market by Country
3.1.1.1 LAMEA Stroke Management Market by Diagnostics Type
3.1.1.1.1 LAMEA Stroke Management Computed Tomography Scan (CT Scan) Market by Country
3.1.1.1.2 LAMEA Stroke Management Magnetic Resonance Imaging (MRI) Market by Country
3.1.1.1.3 LAMEA Stroke Management Echocardiography Market by Country
3.1.1.1.4 LAMEA Stroke Management Carotid Ultrasound Market by Country
3.1.1.1.5 LAMEA Stroke Management Cerebral Angiography Market by Country
3.1.1.1.6 LAMEA Stroke Management Electrocardiography Market by Country
3.1.1.1.7 LAMEA Other Diagnostics Type Stroke Management Market by Country
3.1.2 LAMEA Therapeutics Stroke Management Market by Country
3.1.2.1 LAMEA Stroke Management Market by Therapeutics Type
3.1.2.1.1 LAMEA Tissue Plasminogen Activator Stroke Management Market by Country
3.1.2.1.2 LAMEA Anticoagulant Stroke Management Market by Country
3.1.2.1.3 LAMEA Antiplatelet Stroke Management Market by Country
3.1.2.1.4 LAMEA Other Therapeutics Type Stroke Management Market by Country
CHAPTER 4. LAMEA STROKE MANAGEMENT MARKET BY APPLICATION
4.1.1 LAMEA Ischemic Stroke Management Market by Country
4.1.2 LAMEA Hemorrhagic Stroke Management Market by Country
CHAPTER 5. LAMEA STROKE MANAGEMENT MARKET BY COUNTRY
5.1 Brazil Stroke Management Market
5.1.1 Brazil Stroke Management Market by Type
5.1.1.1 Brazil Stroke Management Market by Diagnostics Type
5.1.1.2 Brazil Stroke Management Market by Therapeutics Type
5.1.2 Brazil Stroke Management Market by Application
5.2 Argentina Stroke Management Market
5.2.1 Argentina Stroke Management Market by Type
5.2.1.1 Argentina Stroke Management Market by Diagnostics Type
5.2.1.2 Argentina Stroke Management Market by Therapeutics Type
5.2.2 Argentina Stroke Management Market by Application
5.3 UAE Stroke Management Market
5.3.1 UAE Stroke Management Market by Type
5.3.1.1 UAE Stroke Management Market by Diagnostics Type
5.3.1.2 UAE Stroke Management Market by Therapeutics Type
5.3.2 UAE Stroke Management Market by Application
5.4 Saudi Arabia Stroke Management Market
5.4.1 Saudi Arabia Stroke Management Market by Type
5.4.1.1 Saudi Arabia Stroke Management Market by Diagnostics Type
5.4.1.2 Saudi Arabia Stroke Management Market by Therapeutics Type
5.4.2 Saudi Arabia Stroke Management Market by Application
5.5 South Africa Stroke Management Market
5.5.1 South Africa Stroke Management Market by Type
5.5.1.1 South Africa Stroke Management Market by Diagnostics Type
5.5.1.2 South Africa Stroke Management Market by Therapeutics Type
5.5.2 South Africa Stroke Management Market by Application
5.6 Nigeria Stroke Management Market
5.6.1 Nigeria Stroke Management Market by Type
5.6.1.1 Nigeria Stroke Management Market by Diagnostics Type
5.6.1.2 Nigeria Stroke Management Market by Therapeutics Type
5.6.2 Nigeria Stroke Management Market by Application
5.7 Rest of LAMEA Stroke Management Market
5.7.1 Rest of LAMEA Stroke Management Market by Type
5.7.1.1 Rest of LAMEA Stroke Management Market by Diagnostics Type
5.7.1.2 Rest of LAMEA Stroke Management Market by Therapeutics Type
5.7.2 Rest of LAMEA Stroke Management Market by Application
CHAPTER 6. COMPANY PROFILES
6.1 B. Braun Melsungen AG.
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental Analysis
6.1.4 Research & Development Expense
6.2 ABBOTT
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Regional & Segmental Analysis
6.2.4 Research & Development Expense
6.3 Cardinal Health
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental Analysis
6.4 Medtronic Plc.
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expense
6.5 General Electric (GE) (GE Healthcare)
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.5.4 Research & Development Expense
6.6 Siemens Healthineers
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental Analysis
6.6.4 Research & Development Expense
6.7 Bristol-Myers Squibb
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Regional Analysis
6.7.4 Research & Development Expense
6.8 Merck & Company Inc.
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental Analysis
6.8.4 Research & Development Expense
6.9 Glaxosmithkline Plc.
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Segmental Analysis
6.9.4 Research & Development Expense
LIST OF TABLES
TABLE 1 LAMEA STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
TABLE 2 LAMEA STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
TABLE 3 LAMEA STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
TABLE 4 LAMEA STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
TABLE 5 LAMEA DIAGNOSTICS STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 6 LAMEA DIAGNOSTICS STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 7 LAMEA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
TABLE 8 LAMEA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
TABLE 9 LAMEA STROKE MANAGEMENT COMPUTED TOMOGRAPHY SCAN (CT SCAN) MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 10 LAMEA STROKE MANAGEMENT COMPUTED TOMOGRAPHY SCAN (CT SCAN) MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 11 LAMEA STROKE MANAGEMENT MAGNETIC RESONANCE IMAGING (MRI) MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 12 LAMEA STROKE MANAGEMENT MAGNETIC RESONANCE IMAGING (MRI) MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 13 LAMEA STROKE MANAGEMENT ECHOCARDIOGRAPHY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 14 LAMEA STROKE MANAGEMENT ECHOCARDIOGRAPHY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 15 LAMEA STROKE MANAGEMENT CAROTID ULTRASOUND MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 16 LAMEA STROKE MANAGEMENT CAROTID ULTRASOUND MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 17 LAMEA STROKE MANAGEMENT CEREBRAL ANGIOGRAPHY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 18 LAMEA STROKE MANAGEMENT CEREBRAL ANGIOGRAPHY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 19 LAMEA STROKE MANAGEMENT ELECTROCARDIOGRAPHY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 20 LAMEA STROKE MANAGEMENT ELECTROCARDIOGRAPHY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 21 LAMEA OTHER DIAGNOSTICS TYPE STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 22 LAMEA OTHER DIAGNOSTICS TYPE STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 23 LAMEA THERAPEUTICS STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 24 LAMEA THERAPEUTICS STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 25 LAMEA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
TABLE 26 LAMEA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
TABLE 27 LAMEA TISSUE PLASMINOGEN ACTIVATOR STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 28 LAMEA TISSUE PLASMINOGEN ACTIVATOR STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 29 LAMEA ANTICOAGULANT STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 30 LAMEA ANTICOAGULANT STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 31 LAMEA ANTIPLATELET STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 32 LAMEA ANTIPLATELET STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 33 LAMEA OTHER THERAPEUTICS TYPE STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 34 LAMEA OTHER THERAPEUTICS TYPE STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 35 LAMEA STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 36 LAMEA STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 37 LAMEA ISCHEMIC STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 38 LAMEA ISCHEMIC STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 39 LAMEA HAEMORRHAGIC STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 40 LAMEA HAEMORRHAGIC STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 41 LAMEA STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 42 LAMEA STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 43 BRAZIL STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
TABLE 44 BRAZIL STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
TABLE 45 BRAZIL STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
TABLE 46 BRAZIL STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
TABLE 47 BRAZIL STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
TABLE 48 BRAZIL STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
TABLE 49 BRAZIL STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
TABLE 50 BRAZIL STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
TABLE 51 BRAZIL STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 52 BRAZIL STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 53 ARGENTINA STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
TABLE 54 ARGENTINA STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
TABLE 55 ARGENTINA STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
TABLE 56 ARGENTINA STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
TABLE 57 ARGENTINA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
TABLE 58 ARGENTINA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
TABLE 59 ARGENTINA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
TABLE 60 ARGENTINA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
TABLE 61 ARGENTINA STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 62 ARGENTINA STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 63 UAE STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
TABLE 64 UAE STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
TABLE 65 UAE STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
TABLE 66 UAE STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
TABLE 67 UAE STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
TABLE 68 UAE STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
TABLE 69 UAE STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
TABLE 70 UAE STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
TABLE 71 UAE STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 72 UAE STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 73 SAUDI ARABIA STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
TABLE 74 SAUDI ARABIA STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
TABLE 75 SAUDI ARABIA STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
TABLE 76 SAUDI ARABIA STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
TABLE 77 SAUDI ARABIA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
TABLE 78 SAUDI ARABIA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
TABLE 79 SAUDI ARABIA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
TABLE 80 SAUDI ARABIA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
TABLE 81 SAUDI ARABIA STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 82 SAUDI ARABIA STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 83 SOUTH AFRICA STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
TABLE 84 SOUTH AFRICA STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
TABLE 85 SOUTH AFRICA STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
TABLE 86 SOUTH AFRICA STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
TABLE 87 SOUTH AFRICA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
TABLE 88 SOUTH AFRICA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
TABLE 89 SOUTH AFRICA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
TABLE 90 SOUTH AFRICA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
TABLE 91 SOUTH AFRICA STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 92 SOUTH AFRICA STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 93 NIGERIA STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
TABLE 94 NIGERIA STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
TABLE 95 NIGERIA STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
TABLE 96 NIGERIA STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
TABLE 97 NIGERIA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
TABLE 98 NIGERIA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
TABLE 99 NIGERIA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
TABLE 100 NIGERIA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
TABLE 101 NIGERIA STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 102 NIGERIA STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 103 REST OF LAMEA STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
TABLE 104 REST OF LAMEA STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
TABLE 105 REST OF LAMEA STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
TABLE 106 REST OF LAMEA STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
TABLE 107 REST OF LAMEA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
TABLE 108 REST OF LAMEA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
TABLE 109 REST OF LAMEA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
TABLE 110 REST OF LAMEA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
TABLE 111 REST OF LAMEA STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 112 REST OF LAMEA STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 113 KEY INFORMATION – B. BRAUN MELSUNGEN AG
TABLE 114 KEY INFORMATION – ABBOTT
TABLE 115 KEY INFORMATION – CARDINAL HEALTH
TABLE 116 BUSINESS SEGMENT – CARDINAL HEALTH
TABLE 117 KEY INFORMATION – MEDTRONIC PLC
TABLE 118 KEY INFORMATION – MEDTRONIC
TABLE 119 KEY INFORMATION – GENERAL ELECTRIC (GE)
TABLE 120 KEY INFORMATION - SIEMENS HEALTHINEERS
TABLE 121 KEY INFORMATION - BRISTOL-MYERS SQUIBB
TABLE 122 KEY INFORMATION - MERCK & COMPANY INC.
TABLE 123 KEY INFORMATION - GLAXOSMITHKLINE PLC.
TABLE 1 LAMEA STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
TABLE 2 LAMEA STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
TABLE 3 LAMEA STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
TABLE 4 LAMEA STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
TABLE 5 LAMEA DIAGNOSTICS STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 6 LAMEA DIAGNOSTICS STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 7 LAMEA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
TABLE 8 LAMEA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
TABLE 9 LAMEA STROKE MANAGEMENT COMPUTED TOMOGRAPHY SCAN (CT SCAN) MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 10 LAMEA STROKE MANAGEMENT COMPUTED TOMOGRAPHY SCAN (CT SCAN) MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 11 LAMEA STROKE MANAGEMENT MAGNETIC RESONANCE IMAGING (MRI) MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 12 LAMEA STROKE MANAGEMENT MAGNETIC RESONANCE IMAGING (MRI) MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 13 LAMEA STROKE MANAGEMENT ECHOCARDIOGRAPHY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 14 LAMEA STROKE MANAGEMENT ECHOCARDIOGRAPHY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 15 LAMEA STROKE MANAGEMENT CAROTID ULTRASOUND MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 16 LAMEA STROKE MANAGEMENT CAROTID ULTRASOUND MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 17 LAMEA STROKE MANAGEMENT CEREBRAL ANGIOGRAPHY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 18 LAMEA STROKE MANAGEMENT CEREBRAL ANGIOGRAPHY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 19 LAMEA STROKE MANAGEMENT ELECTROCARDIOGRAPHY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 20 LAMEA STROKE MANAGEMENT ELECTROCARDIOGRAPHY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 21 LAMEA OTHER DIAGNOSTICS TYPE STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 22 LAMEA OTHER DIAGNOSTICS TYPE STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 23 LAMEA THERAPEUTICS STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 24 LAMEA THERAPEUTICS STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 25 LAMEA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
TABLE 26 LAMEA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
TABLE 27 LAMEA TISSUE PLASMINOGEN ACTIVATOR STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 28 LAMEA TISSUE PLASMINOGEN ACTIVATOR STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 29 LAMEA ANTICOAGULANT STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 30 LAMEA ANTICOAGULANT STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 31 LAMEA ANTIPLATELET STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 32 LAMEA ANTIPLATELET STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 33 LAMEA OTHER THERAPEUTICS TYPE STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 34 LAMEA OTHER THERAPEUTICS TYPE STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 35 LAMEA STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 36 LAMEA STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 37 LAMEA ISCHEMIC STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 38 LAMEA ISCHEMIC STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 39 LAMEA HAEMORRHAGIC STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 40 LAMEA HAEMORRHAGIC STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 41 LAMEA STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 42 LAMEA STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 43 BRAZIL STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
TABLE 44 BRAZIL STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
TABLE 45 BRAZIL STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
TABLE 46 BRAZIL STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
TABLE 47 BRAZIL STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
TABLE 48 BRAZIL STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
TABLE 49 BRAZIL STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
TABLE 50 BRAZIL STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
TABLE 51 BRAZIL STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 52 BRAZIL STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 53 ARGENTINA STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
TABLE 54 ARGENTINA STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
TABLE 55 ARGENTINA STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
TABLE 56 ARGENTINA STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
TABLE 57 ARGENTINA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
TABLE 58 ARGENTINA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
TABLE 59 ARGENTINA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
TABLE 60 ARGENTINA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
TABLE 61 ARGENTINA STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 62 ARGENTINA STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 63 UAE STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
TABLE 64 UAE STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
TABLE 65 UAE STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
TABLE 66 UAE STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
TABLE 67 UAE STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
TABLE 68 UAE STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
TABLE 69 UAE STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
TABLE 70 UAE STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
TABLE 71 UAE STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 72 UAE STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 73 SAUDI ARABIA STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
TABLE 74 SAUDI ARABIA STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
TABLE 75 SAUDI ARABIA STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
TABLE 76 SAUDI ARABIA STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
TABLE 77 SAUDI ARABIA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
TABLE 78 SAUDI ARABIA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
TABLE 79 SAUDI ARABIA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
TABLE 80 SAUDI ARABIA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
TABLE 81 SAUDI ARABIA STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 82 SAUDI ARABIA STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 83 SOUTH AFRICA STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
TABLE 84 SOUTH AFRICA STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
TABLE 85 SOUTH AFRICA STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
TABLE 86 SOUTH AFRICA STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
TABLE 87 SOUTH AFRICA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
TABLE 88 SOUTH AFRICA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
TABLE 89 SOUTH AFRICA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
TABLE 90 SOUTH AFRICA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
TABLE 91 SOUTH AFRICA STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 92 SOUTH AFRICA STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 93 NIGERIA STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
TABLE 94 NIGERIA STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
TABLE 95 NIGERIA STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
TABLE 96 NIGERIA STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
TABLE 97 NIGERIA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
TABLE 98 NIGERIA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
TABLE 99 NIGERIA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
TABLE 100 NIGERIA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
TABLE 101 NIGERIA STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 102 NIGERIA STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 103 REST OF LAMEA STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
TABLE 104 REST OF LAMEA STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
TABLE 105 REST OF LAMEA STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
TABLE 106 REST OF LAMEA STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
TABLE 107 REST OF LAMEA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
TABLE 108 REST OF LAMEA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
TABLE 109 REST OF LAMEA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
TABLE 110 REST OF LAMEA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
TABLE 111 REST OF LAMEA STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 112 REST OF LAMEA STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 113 KEY INFORMATION – B. BRAUN MELSUNGEN AG
TABLE 114 KEY INFORMATION – ABBOTT
TABLE 115 KEY INFORMATION – CARDINAL HEALTH
TABLE 116 BUSINESS SEGMENT – CARDINAL HEALTH
TABLE 117 KEY INFORMATION – MEDTRONIC PLC
TABLE 118 KEY INFORMATION – MEDTRONIC
TABLE 119 KEY INFORMATION – GENERAL ELECTRIC (GE)
TABLE 120 KEY INFORMATION - SIEMENS HEALTHINEERS
TABLE 121 KEY INFORMATION - BRISTOL-MYERS SQUIBB
TABLE 122 KEY INFORMATION - MERCK & COMPANY INC.
TABLE 123 KEY INFORMATION - GLAXOSMITHKLINE PLC.
